High Tower Advisors, LLC Gilead Sciences, Inc. Put Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $7,180 - $8,142	98 Added 4900.0%	100 $8,000
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $73 - $80	-1 Reduced 33.33%	2 $0
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $228 - $260	3 New	3 $0
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $62 - $89	-1 Reduced 50.0%	1 $0
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $119 - $136	2 New	2 $1,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $6,423 - $7,290	-99 Reduced 99.0%	1 $2,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $6,769 - $7,303	100 New	100 $1,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.